BridgeMD
New treatment option for Myeloproliferative Neoplasm
Official title Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
ClinicalTrials.gov ID: NCT06361641
What this study is testing
- What it's testing
- Prospective study for functional and phenotypic characterization of monocytes in philadelphia-negative myeloproliferative neoplasms
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of PV, ET, pre-myelofibrosis or primary myelofibrosis according to WHO 2022 criteria (including BOM for ET, premyelofibrosis and primary...
- Patient who has not received treatment specific to hemopathy at the time of sampling
- Obtaining the signature of consent to participate in the study
- Patient having consented to be included in the "Malignant Hemopathy" collection of Angers University Hospital and in FIMBANK database
You likely can't join if
- Person not affiliated to a social security scheme or beneficiary of such a scheme
- Patient with another hemopathy or another active cancer at the time of diagnosis
- Minor patient at diagnosis (\< 18 years old)
- Patient not capable or without agreement from the guardian or legal representative
The study team makes the final eligibility decision.
Where it's taking place
- Angers, Maine et Loire, France
- Cholet, Maine et Loire, France
- Saumur, Maine et Loire, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, Maine et Loire, France; Cholet, Maine et Loire, France; Saumur, Maine et Loire, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.